BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29203892)

  • 1. Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement.
    De Nunzio C; Brassetti A; Proietti F; Deroma M; Esperto F; Tubaro A
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):287-292. PubMed ID: 29203892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate.
    De Nunzio C; Tema G; Lombardo R; Cicione A; Nacchia A; D'Annunzio S; Sarchi L; Proietti F; Brassetti A; Tubaro A
    Neurourol Urodyn; 2019 Aug; 38(6):1692-1699. PubMed ID: 31107572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
    De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
    Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is obstructive sleep apnea syndrome related to nocturia?
    Arslan B; Gezmis CT; Çetin B; Gönültas S; Gökmen E; Gürkan O; Ozdemir E
    Low Urin Tract Symptoms; 2019 May; 11(3):139-142. PubMed ID: 30548821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Syndrome Does Not Increase the Risk of Ejaculatory Dysfunction in Patients With Lower Urinary Tract Symptoms and Benign Prostatic Enlargement: An Italian Single-center Cohort Study.
    De Nunzio C; Lombardo R; Gacci M; Nacchia A; Presicce F; Alkhatatbeh H; Serni S; Tubaro A
    Urology; 2017 Jul; 105():85-90. PubMed ID: 28412335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
    Sebastianelli A; Gacci M
    Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of age, metabolic syndrome, nocturnal polyuria and sleep disorders on nocturia.
    Sağlam HS; Gökkaya CS; Salar R; Memiş A; Adsan O
    Adv Clin Exp Med; 2013; 22(4):489-94. PubMed ID: 23986208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
    Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum testosterone and nocturia in men without benign prostate enlargement.
    Jeh SU; Yoon S; Seo DH; Lee SW; Lee C; Choi SM; Kam SC; Hwa JS; Chung KH; Hyun JS
    Andrology; 2017 Jan; 5(1):58-62. PubMed ID: 27636882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.